TRI facility · TRI 2024 reporting year

Takasago International Corp (Usa)

Total reported releases 117 lb held roughly steady year over year (-2%). Total releases concentrations have more than doubled since 2014.

114 COMMERCE DRIVE, Harriman, New York · 325620 · Chemicals · operated by Takasago International CORP USA

TOTAL RELEASES · 20142024
Bar chart of annual values from 2014 to 2024, in lb. Most recent year (2024): 117.133'14'16'18'20'22'24117
Anomaly engine

Notable Signals

No notable signals at this facility for the current reporting year. See chemicals and equity context below for the full picture.

Chemicals reported · most recent year

What This Facility Releases

PBTCAS 1222-05-5

1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethylcyclopenta[g]-2-benzopyran

97 lb · -5% YoY

1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethylcyclopenta[g]-2-benzopyran concentrations are roughly unchanged from 2023.

RESPIRATORYCAS N230

Certain glycol ethers

21 lb · +19% YoY

Certain glycol ethers concentrations have more than doubled since 2014.

Equity context · ACS 2018-2022 block-group demographics

Who Lives Next To This Facility

Within 3 miles of this facility (21 Census block groups, population-weighted demographics): a population of 39,015. Why we surface this →

POPULATION SHARE
52.6%

Low-income

POPULATION SHARE
21.9%

People of color

POPULATION SHARE
14.5%

Under age 5

POPULATION SHARE
7.2%

Over age 64

Source: Census ACS 2018-2022 block-group demographics, population-weighted across the 3-mile buffer around this facility (from USEPA-clone/EJAM-open blockgroupstats). Indicator-level percentile and EJ-disparity scores are surfaced on the county page and the state page — they describe wider regional exposure burdens, not effects attributable to a single facility.

Source. EPA Toxics Release Inventory · retrieved 2026-05-07. Reporting year 2024. TRI is a federal public-domain dataset under 17 USC §105.

What this is not. TRI quantifies releases reported by the facility under EPCRA §313 — not ambient air or water concentrations measured at receptors. We do not attribute individual health outcomes to specific facilities; that exceeds what the data can support.